ID   IF5_RAT                 Reviewed;         429 AA.
AC   Q07205;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   29-MAY-2024, entry version 167.
DE   RecName: Full=Eukaryotic translation initiation factor 5;
DE            Short=eIF-5;
GN   Name=Eif5;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 131-150; 215-242 AND
RP   339-353.
RC   TISSUE=Liver;
RX   PubMed=8464924; DOI=10.1073/pnas.90.7.3058;
RA   Das K., Chevesich J., Maitra U.;
RT   "Molecular cloning and expression of cDNA for mammalian translation
RT   initiation factor 5.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:3058-3062(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PHOSPHORYLATION AT SER-387 AND SER-388.
RX   PubMed=11861906; DOI=10.1093/nar/30.5.1154;
RA   Majumdar R., Bandyopadhyay A., Deng H., Maitra U.;
RT   "Phosphorylation of mammalian translation initiation factor 5 (eIF5) in
RT   vitro and in vivo.";
RL   Nucleic Acids Res. 30:1154-1162(2002).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-227; SER-387 AND
RP   SER-388, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of the 43S pre-initiation complex (43S PIC), which
CC       binds to the mRNA cap-proximal region, scans mRNA 5'-untranslated
CC       region, and locates the initiation codon. In this complex, acts as a
CC       GTPase-activating protein, by promoting GTP hydrolysis by eIF2G
CC       (EIF2S3). During scanning, interacts with both EIF1 (via its C-terminal
CC       domain (CTD)) and EIF1A (via its NTD). This interaction with EIF1A
CC       contributes to the maintenance of EIF1 within the open 43S PIC. When
CC       start codon is recognized, EIF5, via its NTD, induces eIF2G (EIF2S3) to
CC       hydrolyze the GTP. Start codon recognition also induces a
CC       conformational change of the PIC to a closed state. This change
CC       increases the affinity of EIF5-CTD for EIF2-beta (EIF2S2), which allows
CC       the release, by an indirect mechanism, of EIF1 from the PIC. Finally,
CC       EIF5 stabilizes the PIC in its closed conformation.
CC       {ECO:0000250|UniProtKB:P55010}.
CC   -!- SUBUNIT: Component of the 43S pre-initiation complex (43S PIC), which
CC       is composed of the 40S ribosomal subunit, EIF1, eIF1A (EIF1AX), eIF3
CC       complex, EIF5 and eIF2-GTP-initiator tRNA complex (eIF2 ternary
CC       complex). Interacts with eIF1A (EIF1AX) during scanning. Interacts
CC       through its C-terminal domain (CTD) with EIF1 or with eIF2-beta
CC       (EIF2S2) (mutually exclusive) through a common binding site. Interacts
CC       through its C-terminal domain (CTD) with the CTD of EIF5B. Interacts
CC       with FMR1 isoform 6; this interaction occurs in a RNA-dependent manner.
CC       {ECO:0000250|UniProtKB:P55010}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the eIF-2-beta/eIF-5 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L11651; AAA41112.1; -; mRNA.
DR   EMBL; BC062398; AAH62398.1; -; mRNA.
DR   PIR; A47305; A47305.
DR   RefSeq; NP_001316808.1; NM_001329879.1.
DR   RefSeq; NP_064460.1; NM_020075.1.
DR   RefSeq; XP_006240671.1; XM_006240609.3.
DR   RefSeq; XP_017458786.1; XM_017603297.1.
DR   AlphaFoldDB; Q07205; -.
DR   BMRB; Q07205; -.
DR   SMR; Q07205; -.
DR   BioGRID; 248584; 2.
DR   IntAct; Q07205; 2.
DR   STRING; 10116.ENSRNOP00000013695; -.
DR   iPTMnet; Q07205; -.
DR   PhosphoSitePlus; Q07205; -.
DR   SwissPalm; Q07205; -.
DR   jPOST; Q07205; -.
DR   PaxDb; 10116-ENSRNOP00000013695; -.
DR   Ensembl; ENSRNOT00000013695.8; ENSRNOP00000013695.6; ENSRNOG00000010218.8.
DR   Ensembl; ENSRNOT00055048637; ENSRNOP00055039981; ENSRNOG00055028084.
DR   Ensembl; ENSRNOT00060046908; ENSRNOP00060039008; ENSRNOG00060027016.
DR   Ensembl; ENSRNOT00065043439; ENSRNOP00065035632; ENSRNOG00065025212.
DR   GeneID; 108348073; -.
DR   KEGG; rno:108348073; -.
DR   UCSC; RGD:619861; rat.
DR   AGR; RGD:619861; -.
DR   CTD; 1983; -.
DR   RGD; 619861; Eif5.
DR   eggNOG; KOG2767; Eukaryota.
DR   GeneTree; ENSGT00390000016478; -.
DR   HOGENOM; CLU_026663_1_0_1; -.
DR   InParanoid; Q07205; -.
DR   OMA; YRYKMEK; -.
DR   OrthoDB; 5475947at2759; -.
DR   PhylomeDB; Q07205; -.
DR   Reactome; R-RNO-72702; Ribosomal scanning and start codon recognition.
DR   PRO; PR:Q07205; -.
DR   Proteomes; UP000002494; Chromosome 6.
DR   Bgee; ENSRNOG00000010218; Expressed in ileum and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0071074; F:eukaryotic initiation factor eIF2 binding; IDA:RGD.
DR   GO; GO:0005092; F:GDP-dissociation inhibitor activity; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0003743; F:translation initiation factor activity; IDA:RGD.
DR   GO; GO:0001732; P:formation of cytoplasmic translation initiation complex; IBA:GO_Central.
DR   GO; GO:0001731; P:formation of translation preinitiation complex; IDA:RGD.
DR   GO; GO:0006446; P:regulation of translational initiation; ISO:RGD.
DR   GO; GO:0042255; P:ribosome assembly; ISO:RGD.
DR   CDD; cd11561; W2_eIF5; 1.
DR   Gene3D; 1.25.40.180; -; 1.
DR   Gene3D; 2.20.25.350; -; 1.
DR   Gene3D; 3.30.30.170; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR045196; IF2/IF5.
DR   InterPro; IPR002735; Transl_init_fac_IF2/IF5_dom.
DR   InterPro; IPR016189; Transl_init_fac_IF2/IF5_N.
DR   InterPro; IPR016190; Transl_init_fac_IF2/IF5_Zn-bd.
DR   InterPro; IPR003307; W2_domain.
DR   PANTHER; PTHR23001; EUKARYOTIC TRANSLATION INITIATION FACTOR; 1.
DR   PANTHER; PTHR23001:SF7; EUKARYOTIC TRANSLATION INITIATION FACTOR 5; 1.
DR   Pfam; PF01873; eIF-5_eIF-2B; 1.
DR   Pfam; PF02020; W2; 1.
DR   SMART; SM00653; eIF2B_5; 1.
DR   SMART; SM00515; eIF5C; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF100966; Translation initiation factor 2 beta, aIF2beta, N-terminal domain; 1.
DR   SUPFAM; SSF75689; Zinc-binding domain of translation initiation factor 2 beta; 1.
DR   PROSITE; PS51363; W2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; GTP-binding; GTPase activation;
KW   Initiation factor; Isopeptide bond; Nucleotide-binding; Phosphoprotein;
KW   Protein biosynthesis; Reference proteome; Ubl conjugation.
FT   CHAIN           1..429
FT                   /note="Eukaryotic translation initiation factor 5"
FT                   /id="PRO_0000212518"
FT   DOMAIN          231..390
FT                   /note="W2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00695"
FT   REGION          143..216
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        150..171
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         27..34
FT                   /ligand="GTP"
FT                   /ligand_id="ChEBI:CHEBI:37565"
FT                   /evidence="ECO:0000255"
FT   SITE            15
FT                   /note="Arginine finger"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         225
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
FT   MOD_RES         227
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         387
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11861906,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         388
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11861906,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         408
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
FT   MOD_RES         417
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
FT   CROSSLNK        411
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
FT   CROSSLNK        416
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P55010"
SQ   SEQUENCE   429 AA;  48954 MW;  B1A62E30936908EE CRC64;
     MSVNVNRSVS DQFYRYKMPR LIAKVEGKGN GIKTVIVNMV DVAKALNRPP TYPTKYFGCE
     LGAQTQFDVK NDRYIVNGSH EANKLQDMLD GFIKKFVLCP ECENPETDLH VNPKKQTIGN
     SCKACGYRGM LDTHHKLCTF ILKNPPENSD IGTGKKEKEK KNRKGKDKEN GSVSTSETPP
     PPPPNEISPP HAVEEEEDDD WGEDTTEEAQ RRRMDEISDH AKGLTLSDDL ERTVEERVNI
     LFDFVKKKKE EGIIDSSDKD IVAEAERLDV KAMGPLVLTE VLFDEKIREQ IKKYRRHFLR
     FCHNNKKAQR YLLHGLECVV AMHQAQLISK IPHILKEMYD ADLLEEEVII SWSEKASKKY
     VSKELAKEIR VKAEPFIKWL KEAEEESSGG EEEDEDENIE VVYSKTASVP KVETVKSDNK
     DDDIDIDAI
//
